We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
(-20%)
Cap. Flow
+$65.2M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$25.6M |
| 2 |
Vipshop
VIPS
|
+$16.3M |
| 3 |
DigitalBridge
DBRG
|
+$15.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$10.9M |
| 5 |
ALBO
Albireo Pharma Inc
ALBO
|
+$5.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$57.6M |
| 2 |
Bath & Body Works
BBWI
|
+$22.6M |
| 3 |
Bilibili
BILI
|
+$13M |
| 4 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$12.3M |
| 5 |
Gilead Sciences
GILD
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.37% |
| 2 | Financials | 7.66% |
| 3 | Consumer Discretionary | 5.31% |
| 4 | Communication Services | 3.82% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
101
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.38M | 0.08% |
122,999
+85,425
| +227% | +$1.73M |
|
102
Waste Management
WM
$90.6B
| $1.37M | 0.08% |
15,600
+400
| +3% | +$35.9K |
|
|
MYOK
103
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.36M | 0.08% |
+26,513
| New | +$1.46M |
|
104
AnaptysBio
ANAB
$1.58B
| $1.33M | 0.08% |
+21,596
| New | +$1.61M |
|
|
EIDX
105
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $1.31M | 0.08% |
+94,270
| New | +$1.19M |
|
106
Travere Therapeutics
TVTX
$5.2B
| $1.26M | 0.08% |
+56,837
| New | +$1.41M |
|
107
McKesson
MCK
$100B
| $1.22M | 0.07% |
11,085
| – | – |
|
|
PTLA
108
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.21M | 0.07% |
+74,800
| New | +$1.54M |
|
109
KALA BIO
KALA
$14.1M
| $1.21M | 0.07% |
+99
| New | +$1.72M |
|
|
PRTK
110
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.2M | 0.07% |
+227,383
| New | +$1.73M |
|
|
DRNA
111
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.15M | 0.07% |
+113,938
| New | +$1.5M |
|
112
Goldman Sachs
GS
$300B
| $1.15M | 0.07% |
+6,915
| New | +$1.39M |
|
113
Cisco
CSCO
$457B
| $1.15M | 0.07% |
26,700
+14,210
| +114% | +$650K |
|
114
Cytokinetics
CYTK
$10.5B
| $1.11M | 0.07% |
+177,792
| New | +$1.3M |
|
|
IMGN
115
DELISTED
Immunogen Inc
IMGN
| $1.11M | 0.07% |
248,749
+70,000
| +39% | +$425K |
|
|
SPPI
116
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.07M | 0.06% |
+121,000
| New | +$1.54M |
|
117
Delta Air Lines
DAL
$57.5B
| $1.07M | 0.06% |
21,311
-4,600
| -18% | -$250K |
|
|
CCXI
118
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.06M | 0.06% |
100,976
-58,074
| -37% | -$612K |
|
119
Ultragenyx Pharmaceutical
RARE
$2.45B
| $1.05M | 0.06% |
25,000
-13,500
| -35% | -$738K |
|
120
Spero Therapeutics
SPRO
$67.7M
| $1.04M | 0.06% |
+162,362
| New | +$1.31M |
|
121
General Dynamics
GD
$104B
| $1.04M | 0.06% |
6,588
+1,588
| +32% | +$285K |
|
122
Zymeworks
ZYME
$1.61B
| $1.03M | 0.06% |
+88,008
| New | +$1.15M |
|
|
PPLI
123
People Inc
PPLI
$3.09B
| $1.01M | 0.06% |
30,775
-7,833
| -20% | -$263K |
|
124
Bank of America
BAC
$435B
| $1M | 0.06% |
40,783
+31,383
| +334% | +$851K |
|
125
Boeing
BA
$171B
| $967K | 0.06% |
3,050
+2,195
| +257% | +$758K |
|
Similar funds
NC
T2I
BA
IAA
THL
MHC
BWM
KHCM
Fosun International's Q4 2018 Portfolio in Review
As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.
- Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
- Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
- Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
- Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
- Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
- Fosun International opened 97 new positions and closed 44 in Q4 2018.
- Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.
Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.